Immunologists at St. Jude Children’s Research Hospital have identified biochemical “switches” that control development of regulatory T cells and offer a novel strategy for treatment of autoimmune diseases and cancer. The research appeared earlier this month in the journal Cell Reports.
Click here for original story, Secrets of regulatory T cell development reveal clinical possibilities
Source: Phys.org